POZEN is a pharmaceutical company that develops products for the treatment of acute chronic pain and pain-related conditions. The company develops therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety and patient convenience. Since its inception, POZEN has focused its efforts primarily on the development of pharmaceutical products for the treatment of acute and chronic pain, migraine or other pain related conditions. Its lead product candidate is Trexima, which is being developed by the company in collaboration with GlaxoSmithKline for the treatment of acute migraine headaches. POZEN is headquartered in Chapel Hill, N.C.